Further evidence of a role for pDCs and IFN-α in the expansion of CD24+CD38hi Breg cells is provided by data reporting an enrichment of IL-10+CD24hiCD38hi B cells in multiple sclerosis (MS) patients responding to IFN-β therapy (Schubert et al., 2015). Here, IL10 is linked to myeloid sarcoma.